Furthermore, treatment with exogenous IL-8 increases the invasiveness of human pancreatic cancer cell, while blocking IL-8 inhibited the growth of another human pancreatic cancer cell [131]. This evidence concerns the gene CXCL8 and familial pancreatic carcinoma.